nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF2—prostate cancer	0.6	1	CbGaD
Pentosan Polysulfate—FGF2—prostate gland—prostate cancer	0.00488	0.209	CbGeAlD
Pentosan Polysulfate—FGF1—prostate gland—prostate cancer	0.00363	0.155	CbGeAlD
Pentosan Polysulfate—FGF2—urethra—prostate cancer	0.00327	0.14	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—prostate cancer	0.00267	0.114	CbGeAlD
Pentosan Polysulfate—FGF1—renal system—prostate cancer	0.00247	0.106	CbGeAlD
Pentosan Polysulfate—FGF2—testis—prostate cancer	0.00215	0.0919	CbGeAlD
Pentosan Polysulfate—FGF1—testis—prostate cancer	0.0016	0.0684	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—prostate cancer	0.00156	0.0666	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—prostate cancer	0.00116	0.0496	CbGeAlD
Pentosan Polysulfate—Constipation—Mitoxantrone—prostate cancer	0.000102	0.000587	CcSEcCtD
Pentosan Polysulfate—Rash—Goserelin—prostate cancer	0.000101	0.000586	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Goserelin—prostate cancer	0.000101	0.000585	CcSEcCtD
Pentosan Polysulfate—Vomiting—Conjugated Estrogens—prostate cancer	0.000101	0.000585	CcSEcCtD
Pentosan Polysulfate—Urticaria—Estradiol—prostate cancer	0.000101	0.000585	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Estradiol—prostate cancer	0.000101	0.000582	CcSEcCtD
Pentosan Polysulfate—Headache—Goserelin—prostate cancer	0.000101	0.000582	CcSEcCtD
Pentosan Polysulfate—Rash—Conjugated Estrogens—prostate cancer	0.0001	0.00058	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Conjugated Estrogens—prostate cancer	0.0001	0.00058	CcSEcCtD
Pentosan Polysulfate—Headache—Conjugated Estrogens—prostate cancer	9.98e-05	0.000576	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—prostate cancer	9.97e-05	0.000576	CcSEcCtD
Pentosan Polysulfate—Alopecia—Capecitabine—prostate cancer	9.88e-05	0.000571	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—prostate cancer	9.87e-05	0.000571	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—prostate cancer	9.81e-05	0.000567	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Mitoxantrone—prostate cancer	9.78e-05	0.000565	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Mitoxantrone—prostate cancer	9.71e-05	0.000561	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—prostate cancer	9.69e-05	0.00056	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—prostate cancer	9.67e-05	0.000559	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—prostate cancer	9.62e-05	0.000556	CcSEcCtD
Pentosan Polysulfate—Flatulence—Capecitabine—prostate cancer	9.6e-05	0.000555	CcSEcCtD
Pentosan Polysulfate—Nausea—Goserelin—prostate cancer	9.55e-05	0.000552	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—prostate cancer	9.55e-05	0.000552	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—prostate cancer	9.48e-05	0.000548	CcSEcCtD
Pentosan Polysulfate—Nausea—Conjugated Estrogens—prostate cancer	9.46e-05	0.000547	CcSEcCtD
Pentosan Polysulfate—Urticaria—Mitoxantrone—prostate cancer	9.43e-05	0.000545	CcSEcCtD
Pentosan Polysulfate—Anorexia—Etoposide—prostate cancer	9.41e-05	0.000544	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Estradiol—prostate cancer	9.39e-05	0.000543	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Mitoxantrone—prostate cancer	9.39e-05	0.000542	CcSEcCtD
Pentosan Polysulfate—Anaemia—Docetaxel—prostate cancer	9.3e-05	0.000537	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—prostate cancer	9.22e-05	0.000533	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Capecitabine—prostate cancer	9.03e-05	0.000522	CcSEcCtD
Pentosan Polysulfate—Pruritus—Estradiol—prostate cancer	9.02e-05	0.000521	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Docetaxel—prostate cancer	9e-05	0.00052	CcSEcCtD
Pentosan Polysulfate—Anaemia—Capecitabine—prostate cancer	9e-05	0.00052	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—prostate cancer	8.99e-05	0.00052	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—prostate cancer	8.89e-05	0.000514	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—prostate cancer	8.87e-05	0.000513	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—prostate cancer	8.86e-05	0.000512	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—prostate cancer	8.81e-05	0.000509	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Etoposide—prostate cancer	8.81e-05	0.000509	CcSEcCtD
Pentosan Polysulfate—Alopecia—Prednisone—prostate cancer	8.8e-05	0.000509	CcSEcCtD
Pentosan Polysulfate—Malaise—Capecitabine—prostate cancer	8.78e-05	0.000507	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—prostate cancer	8.78e-05	0.000507	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Mitoxantrone—prostate cancer	8.75e-05	0.000506	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Estradiol—prostate cancer	8.72e-05	0.000504	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Capecitabine—prostate cancer	8.72e-05	0.000504	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—prostate cancer	8.59e-05	0.000496	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Docetaxel—prostate cancer	8.56e-05	0.000495	CcSEcCtD
Pentosan Polysulfate—Myalgia—Docetaxel—prostate cancer	8.56e-05	0.000495	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—prostate cancer	8.46e-05	0.000489	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—prostate cancer	8.46e-05	0.000489	CcSEcCtD
Pentosan Polysulfate—Constipation—Etoposide—prostate cancer	8.45e-05	0.000488	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—prostate cancer	8.44e-05	0.000488	CcSEcCtD
Pentosan Polysulfate—Dizziness—Estradiol—prostate cancer	8.43e-05	0.000487	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—prostate cancer	8.32e-05	0.000481	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—prostate cancer	8.32e-05	0.000481	CcSEcCtD
Pentosan Polysulfate—Myalgia—Capecitabine—prostate cancer	8.29e-05	0.000479	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Capecitabine—prostate cancer	8.29e-05	0.000479	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—prostate cancer	8.28e-05	0.000478	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—prostate cancer	8.22e-05	0.000475	CcSEcCtD
Pentosan Polysulfate—Oedema—Docetaxel—prostate cancer	8.21e-05	0.000474	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—prostate cancer	8.2e-05	0.000474	CcSEcCtD
Pentosan Polysulfate—Discomfort—Capecitabine—prostate cancer	8.19e-05	0.000473	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—prostate cancer	8.19e-05	0.000473	CcSEcCtD
Pentosan Polysulfate—Infection—Docetaxel—prostate cancer	8.15e-05	0.000471	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—prostate cancer	8.15e-05	0.000471	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—prostate cancer	8.14e-05	0.000471	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Etoposide—prostate cancer	8.14e-05	0.00047	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mitoxantrone—prostate cancer	8.12e-05	0.00047	CcSEcCtD
Pentosan Polysulfate—Vomiting—Estradiol—prostate cancer	8.1e-05	0.000468	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—prostate cancer	8.08e-05	0.000467	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Prednisone—prostate cancer	8.05e-05	0.000465	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Docetaxel—prostate cancer	8.04e-05	0.000464	CcSEcCtD
Pentosan Polysulfate—Rash—Estradiol—prostate cancer	8.04e-05	0.000464	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Estradiol—prostate cancer	8.03e-05	0.000464	CcSEcCtD
Pentosan Polysulfate—Anaemia—Prednisone—prostate cancer	8.02e-05	0.000463	CcSEcCtD
Pentosan Polysulfate—Headache—Estradiol—prostate cancer	7.98e-05	0.000461	CcSEcCtD
Pentosan Polysulfate—Agitation—Prednisone—prostate cancer	7.97e-05	0.000461	CcSEcCtD
Pentosan Polysulfate—Oedema—Capecitabine—prostate cancer	7.95e-05	0.000459	CcSEcCtD
Pentosan Polysulfate—Infection—Capecitabine—prostate cancer	7.9e-05	0.000456	CcSEcCtD
Pentosan Polysulfate—Urticaria—Etoposide—prostate cancer	7.85e-05	0.000453	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—prostate cancer	7.83e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—prostate cancer	7.83e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Anorexia—Docetaxel—prostate cancer	7.82e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Malaise—Prednisone—prostate cancer	7.82e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—prostate cancer	7.81e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—prostate cancer	7.81e-05	0.000451	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—prostate cancer	7.81e-05	0.000451	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Capecitabine—prostate cancer	7.78e-05	0.00045	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—prostate cancer	7.73e-05	0.000447	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—prostate cancer	7.7e-05	0.000445	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Capecitabine—prostate cancer	7.68e-05	0.000444	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—prostate cancer	7.66e-05	0.000443	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—prostate cancer	7.58e-05	0.000438	CcSEcCtD
Pentosan Polysulfate—Anorexia—Capecitabine—prostate cancer	7.58e-05	0.000438	CcSEcCtD
Pentosan Polysulfate—Nausea—Estradiol—prostate cancer	7.57e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mitoxantrone—prostate cancer	7.55e-05	0.000436	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—prostate cancer	7.54e-05	0.000435	CcSEcCtD
Pentosan Polysulfate—Rash—Mitoxantrone—prostate cancer	7.49e-05	0.000433	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mitoxantrone—prostate cancer	7.48e-05	0.000432	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.48e-05	0.000432	CcSEcCtD
Pentosan Polysulfate—Headache—Mitoxantrone—prostate cancer	7.44e-05	0.00043	CcSEcCtD
Pentosan Polysulfate—Insomnia—Docetaxel—prostate cancer	7.42e-05	0.000429	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Prednisone—prostate cancer	7.38e-05	0.000427	CcSEcCtD
Pentosan Polysulfate—Myalgia—Prednisone—prostate cancer	7.38e-05	0.000427	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Docetaxel—prostate cancer	7.37e-05	0.000426	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Docetaxel—prostate cancer	7.32e-05	0.000423	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisone—prostate cancer	7.3e-05	0.000422	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—prostate cancer	7.28e-05	0.000421	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—prostate cancer	7.27e-05	0.00042	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.24e-05	0.000418	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—prostate cancer	7.23e-05	0.000418	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Docetaxel—prostate cancer	7.23e-05	0.000418	CcSEcCtD
Pentosan Polysulfate—Insomnia—Capecitabine—prostate cancer	7.19e-05	0.000415	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—prostate cancer	7.16e-05	0.000414	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Capecitabine—prostate cancer	7.14e-05	0.000412	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Docetaxel—prostate cancer	7.14e-05	0.000412	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Capecitabine—prostate cancer	7.09e-05	0.000409	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisone—prostate cancer	7.08e-05	0.000409	CcSEcCtD
Pentosan Polysulfate—Nausea—Mitoxantrone—prostate cancer	7.05e-05	0.000408	CcSEcCtD
Pentosan Polysulfate—Infection—Prednisone—prostate cancer	7.03e-05	0.000406	CcSEcCtD
Pentosan Polysulfate—Constipation—Docetaxel—prostate cancer	7.02e-05	0.000406	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Capecitabine—prostate cancer	7e-05	0.000404	CcSEcCtD
Pentosan Polysulfate—Pruritus—Etoposide—prostate cancer	6.99e-05	0.000404	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Capecitabine—prostate cancer	6.91e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—prostate cancer	6.89e-05	0.000398	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Prednisone—prostate cancer	6.84e-05	0.000395	CcSEcCtD
Pentosan Polysulfate—Constipation—Capecitabine—prostate cancer	6.8e-05	0.000393	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Docetaxel—prostate cancer	6.76e-05	0.000391	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—prostate cancer	6.76e-05	0.000391	CcSEcCtD
Pentosan Polysulfate—Anorexia—Prednisone—prostate cancer	6.75e-05	0.00039	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—prostate cancer	6.72e-05	0.000389	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Docetaxel—prostate cancer	6.71e-05	0.000388	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—prostate cancer	6.68e-05	0.000386	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Capecitabine—prostate cancer	6.55e-05	0.000378	CcSEcCtD
Pentosan Polysulfate—Dizziness—Etoposide—prostate cancer	6.53e-05	0.000377	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Capecitabine—prostate cancer	6.5e-05	0.000376	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Docetaxel—prostate cancer	6.49e-05	0.000375	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Prednisone—prostate cancer	6.45e-05	0.000373	CcSEcCtD
Pentosan Polysulfate—Insomnia—Prednisone—prostate cancer	6.4e-05	0.00037	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—prostate cancer	6.37e-05	0.000368	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Prednisone—prostate cancer	6.36e-05	0.000367	CcSEcCtD
Pentosan Polysulfate—Urticaria—Capecitabine—prostate cancer	6.31e-05	0.000365	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—prostate cancer	6.29e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Capecitabine—prostate cancer	6.28e-05	0.000363	CcSEcCtD
Pentosan Polysulfate—Vomiting—Etoposide—prostate cancer	6.28e-05	0.000363	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—prostate cancer	6.27e-05	0.000362	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—prostate cancer	6.23e-05	0.00036	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Prednisone—prostate cancer	6.23e-05	0.00036	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—prostate cancer	6.23e-05	0.00036	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—prostate cancer	6.22e-05	0.00036	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—prostate cancer	6.19e-05	0.000358	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—prostate cancer	6.19e-05	0.000357	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Prednisone—prostate cancer	6.15e-05	0.000356	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—prostate cancer	6.12e-05	0.000354	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—prostate cancer	6.07e-05	0.000351	CcSEcCtD
Pentosan Polysulfate—Constipation—Prednisone—prostate cancer	6.05e-05	0.00035	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Docetaxel—prostate cancer	6.05e-05	0.000349	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—prostate cancer	5.87e-05	0.000339	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Capecitabine—prostate cancer	5.86e-05	0.000338	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Prednisone—prostate cancer	5.83e-05	0.000337	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—prostate cancer	5.82e-05	0.000337	CcSEcCtD
Pentosan Polysulfate—Pruritus—Docetaxel—prostate cancer	5.81e-05	0.000336	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—prostate cancer	5.8e-05	0.000335	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Prednisone—prostate cancer	5.79e-05	0.000335	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—prostate cancer	5.78e-05	0.000334	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—prostate cancer	5.78e-05	0.000334	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—prostate cancer	5.77e-05	0.000333	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—prostate cancer	5.71e-05	0.00033	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—prostate cancer	5.66e-05	0.000327	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisone—prostate cancer	5.62e-05	0.000325	CcSEcCtD
Pentosan Polysulfate—Pruritus—Capecitabine—prostate cancer	5.62e-05	0.000325	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—prostate cancer	5.62e-05	0.000325	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Docetaxel—prostate cancer	5.62e-05	0.000325	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Prednisone—prostate cancer	5.6e-05	0.000323	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—prostate cancer	5.54e-05	0.00032	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—prostate cancer	5.5e-05	0.000318	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Capecitabine—prostate cancer	5.44e-05	0.000314	CcSEcCtD
Pentosan Polysulfate—Dizziness—Docetaxel—prostate cancer	5.43e-05	0.000314	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—prostate cancer	5.42e-05	0.000313	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—prostate cancer	5.35e-05	0.000309	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—prostate cancer	5.34e-05	0.000309	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—prostate cancer	5.34e-05	0.000309	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—prostate cancer	5.28e-05	0.000305	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—prostate cancer	5.28e-05	0.000305	CcSEcCtD
Pentosan Polysulfate—Dizziness—Capecitabine—prostate cancer	5.26e-05	0.000304	CcSEcCtD
Pentosan Polysulfate—Vomiting—Docetaxel—prostate cancer	5.22e-05	0.000302	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Prednisone—prostate cancer	5.22e-05	0.000301	CcSEcCtD
Pentosan Polysulfate—Rash—Docetaxel—prostate cancer	5.18e-05	0.000299	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Docetaxel—prostate cancer	5.17e-05	0.000299	CcSEcCtD
Pentosan Polysulfate—Headache—Docetaxel—prostate cancer	5.14e-05	0.000297	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—prostate cancer	5.12e-05	0.000296	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—prostate cancer	5.09e-05	0.000294	CcSEcCtD
Pentosan Polysulfate—Vomiting—Capecitabine—prostate cancer	5.05e-05	0.000292	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.04e-05	0.000292	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—prostate cancer	5.02e-05	0.00029	CcSEcCtD
Pentosan Polysulfate—Rash—Capecitabine—prostate cancer	5.01e-05	0.00029	CcSEcCtD
Pentosan Polysulfate—Pruritus—Prednisone—prostate cancer	5.01e-05	0.000289	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—prostate cancer	5.01e-05	0.000289	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Capecitabine—prostate cancer	5.01e-05	0.000289	CcSEcCtD
Pentosan Polysulfate—Headache—Capecitabine—prostate cancer	4.98e-05	0.000288	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—prostate cancer	4.97e-05	0.000287	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—prostate cancer	4.95e-05	0.000286	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—prostate cancer	4.94e-05	0.000285	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—prostate cancer	4.88e-05	0.000282	CcSEcCtD
Pentosan Polysulfate—Nausea—Docetaxel—prostate cancer	4.88e-05	0.000282	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—prostate cancer	4.87e-05	0.000282	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Prednisone—prostate cancer	4.84e-05	0.00028	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—prostate cancer	4.81e-05	0.000278	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—prostate cancer	4.73e-05	0.000274	CcSEcCtD
Pentosan Polysulfate—Nausea—Capecitabine—prostate cancer	4.72e-05	0.000273	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisone—prostate cancer	4.68e-05	0.000271	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.67e-05	0.00027	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—prostate cancer	4.63e-05	0.000268	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—prostate cancer	4.6e-05	0.000266	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—prostate cancer	4.57e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—prostate cancer	4.56e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—prostate cancer	4.53e-05	0.000262	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—prostate cancer	4.51e-05	0.000261	CcSEcCtD
Pentosan Polysulfate—Vomiting—Prednisone—prostate cancer	4.5e-05	0.00026	CcSEcCtD
Pentosan Polysulfate—Rash—Prednisone—prostate cancer	4.46e-05	0.000258	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisone—prostate cancer	4.46e-05	0.000258	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—prostate cancer	4.45e-05	0.000257	CcSEcCtD
Pentosan Polysulfate—Headache—Prednisone—prostate cancer	4.43e-05	0.000256	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—prostate cancer	4.4e-05	0.000254	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—prostate cancer	4.38e-05	0.000253	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—prostate cancer	4.38e-05	0.000253	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—prostate cancer	4.22e-05	0.000244	CcSEcCtD
Pentosan Polysulfate—Nausea—Prednisone—prostate cancer	4.2e-05	0.000243	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—prostate cancer	4.19e-05	0.000242	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—prostate cancer	4.08e-05	0.000236	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—prostate cancer	4.07e-05	0.000235	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—prostate cancer	4.05e-05	0.000234	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—prostate cancer	3.92e-05	0.000226	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—prostate cancer	3.79e-05	0.000219	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—prostate cancer	3.77e-05	0.000218	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—prostate cancer	3.66e-05	0.000212	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—prostate cancer	3.62e-05	0.000209	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—prostate cancer	3.52e-05	0.000203	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—prostate cancer	3.51e-05	0.000203	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—prostate cancer	3.49e-05	0.000202	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—prostate cancer	3.49e-05	0.000202	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—prostate cancer	3.47e-05	0.0002	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—prostate cancer	3.39e-05	0.000196	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—prostate cancer	3.29e-05	0.00019	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—prostate cancer	3.26e-05	0.000188	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—prostate cancer	3.23e-05	0.000187	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—prostate cancer	3.23e-05	0.000186	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—prostate cancer	3.21e-05	0.000185	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—prostate cancer	3.04e-05	0.000176	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—LPL—prostate cancer	7.54e-06	3.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ITPR1—prostate cancer	7.5e-06	3.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—prostate cancer	7.48e-06	3.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDGFRB—prostate cancer	7.47e-06	3.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOS3—prostate cancer	7.46e-06	3.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CREBBP—prostate cancer	7.46e-06	3.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—prostate cancer	7.43e-06	3.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APC—prostate cancer	7.43e-06	3.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FGF2—prostate cancer	7.42e-06	3.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—prostate cancer	7.4e-06	3.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—prostate cancer	7.39e-06	3.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGF—prostate cancer	7.34e-06	3.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IRS1—prostate cancer	7.34e-06	3.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ITGB3—prostate cancer	7.28e-06	3.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JAK2—prostate cancer	7.25e-06	3.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAP2K1—prostate cancer	7.21e-06	3.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1R—prostate cancer	7.17e-06	3.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CD—prostate cancer	7.16e-06	3.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—prostate cancer	7.14e-06	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—GSK3B—prostate cancer	7.13e-06	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAP2K1—prostate cancer	7.12e-06	3.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JAK2—prostate cancer	7.12e-06	3.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SERPINE1—prostate cancer	7.08e-06	3.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MDM2—prostate cancer	7.08e-06	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—prostate cancer	7.07e-06	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CD—prostate cancer	7.07e-06	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—prostate cancer	7.07e-06	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB3—prostate cancer	7.06e-06	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—prostate cancer	7.06e-06	3.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR2—prostate cancer	7.05e-06	3.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2—prostate cancer	7.05e-06	3.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—prostate cancer	7.04e-06	3.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—INS—prostate cancer	7.03e-06	3.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—prostate cancer	7.02e-06	3.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—prostate cancer	6.98e-06	3.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—prostate cancer	6.95e-06	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—prostate cancer	6.91e-06	3.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CREBBP—prostate cancer	6.89e-06	3.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CB—prostate cancer	6.88e-06	3.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LPL—prostate cancer	6.87e-06	3.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGF2—prostate cancer	6.86e-06	3.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—prostate cancer	6.85e-06	3.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFRB—prostate cancer	6.81e-06	3.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—prostate cancer	6.79e-06	3.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—prostate cancer	6.77e-06	3.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—prostate cancer	6.76e-06	3.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—prostate cancer	6.76e-06	3.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—prostate cancer	6.74e-06	3.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ITGB3—prostate cancer	6.64e-06	3.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—prostate cancer	6.62e-06	3.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAP2K1—prostate cancer	6.57e-06	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—JAK2—prostate cancer	6.57e-06	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—prostate cancer	6.53e-06	3.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—prostate cancer	6.52e-06	3.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—prostate cancer	6.49e-06	3.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JAK2—prostate cancer	6.49e-06	3.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—prostate cancer	6.47e-06	3.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—prostate cancer	6.47e-06	3.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—prostate cancer	6.46e-06	3.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SERPINE1—prostate cancer	6.46e-06	3.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—prostate cancer	6.45e-06	3.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB3—prostate cancer	6.44e-06	3.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR2—prostate cancer	6.43e-06	3.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—prostate cancer	6.43e-06	3.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—prostate cancer	6.41e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—prostate cancer	6.34e-06	3.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—prostate cancer	6.34e-06	3.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—prostate cancer	6.33e-06	3.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—prostate cancer	6.32e-06	3.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—prostate cancer	6.32e-06	3.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LEP—prostate cancer	6.32e-06	3.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—prostate cancer	6.26e-06	3.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CAV1—prostate cancer	6.26e-06	3.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—prostate cancer	6.25e-06	3.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—prostate cancer	6.24e-06	3.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—prostate cancer	6.21e-06	3.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—prostate cancer	6.19e-06	3.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—prostate cancer	6.19e-06	3.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—prostate cancer	6.18e-06	3.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—prostate cancer	6.17e-06	3.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—prostate cancer	6.17e-06	3.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—prostate cancer	6.16e-06	3.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—prostate cancer	6.16e-06	3.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—prostate cancer	6.1e-06	3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—prostate cancer	6.03e-06	2.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—prostate cancer	5.99e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—prostate cancer	5.99e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—JAK2—prostate cancer	5.99e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—prostate cancer	5.98e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—prostate cancer	5.97e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—prostate cancer	5.96e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—prostate cancer	5.95e-06	2.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—prostate cancer	5.9e-06	2.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BAD—prostate cancer	5.89e-06	2.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—prostate cancer	5.86e-06	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—prostate cancer	5.85e-06	2.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—prostate cancer	5.85e-06	2.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—prostate cancer	5.84e-06	2.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—prostate cancer	5.78e-06	2.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—prostate cancer	5.78e-06	2.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—prostate cancer	5.77e-06	2.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LEP—prostate cancer	5.76e-06	2.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—prostate cancer	5.75e-06	2.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—prostate cancer	5.71e-06	2.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CAV1—prostate cancer	5.71e-06	2.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—prostate cancer	5.7e-06	2.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—prostate cancer	5.7e-06	2.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—prostate cancer	5.69e-06	2.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—prostate cancer	5.67e-06	2.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—prostate cancer	5.66e-06	2.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—prostate cancer	5.65e-06	2.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—prostate cancer	5.64e-06	2.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IRS1—prostate cancer	5.64e-06	2.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGF—prostate cancer	5.64e-06	2.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—prostate cancer	5.57e-06	2.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—prostate cancer	5.55e-06	2.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—prostate cancer	5.53e-06	2.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—prostate cancer	5.52e-06	2.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—prostate cancer	5.5e-06	2.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GSK3B—prostate cancer	5.47e-06	2.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—prostate cancer	5.46e-06	2.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—prostate cancer	5.42e-06	2.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—prostate cancer	5.4e-06	2.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—INS—prostate cancer	5.4e-06	2.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—prostate cancer	5.39e-06	2.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—prostate cancer	5.37e-06	2.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BAD—prostate cancer	5.37e-06	2.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—prostate cancer	5.34e-06	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—prostate cancer	5.34e-06	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—prostate cancer	5.33e-06	2.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—prostate cancer	5.32e-06	2.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—prostate cancer	5.31e-06	2.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—prostate cancer	5.3e-06	2.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREBBP—prostate cancer	5.29e-06	2.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—prostate cancer	5.27e-06	2.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—prostate cancer	5.22e-06	2.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—prostate cancer	5.22e-06	2.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—prostate cancer	5.2e-06	2.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—prostate cancer	5.2e-06	2.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—prostate cancer	5.14e-06	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGF—prostate cancer	5.14e-06	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IRS1—prostate cancer	5.14e-06	2.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—prostate cancer	5.08e-06	2.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—prostate cancer	5.06e-06	2.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAP2K1—prostate cancer	5.05e-06	2.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—prostate cancer	5.05e-06	2.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—prostate cancer	5.01e-06	2.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—prostate cancer	5e-06	2.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GSK3B—prostate cancer	4.99e-06	2.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SERPINE1—prostate cancer	4.96e-06	2.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—prostate cancer	4.94e-06	2.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—prostate cancer	4.94e-06	2.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—prostate cancer	4.93e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—prostate cancer	4.93e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—INS—prostate cancer	4.92e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—prostate cancer	4.92e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—prostate cancer	4.9e-06	2.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—prostate cancer	4.84e-06	2.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—prostate cancer	4.82e-06	2.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREBBP—prostate cancer	4.82e-06	2.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGF2—prostate cancer	4.8e-06	2.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—prostate cancer	4.76e-06	2.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—prostate cancer	4.76e-06	2.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—prostate cancer	4.75e-06	2.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—prostate cancer	4.73e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—prostate cancer	4.69e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAP2K1—prostate cancer	4.6e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JAK2—prostate cancer	4.6e-06	2.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—prostate cancer	4.57e-06	2.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—prostate cancer	4.57e-06	2.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—prostate cancer	4.56e-06	2.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SERPINE1—prostate cancer	4.52e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—prostate cancer	4.49e-06	2.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—prostate cancer	4.48e-06	2.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—prostate cancer	4.48e-06	2.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—prostate cancer	4.47e-06	2.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—prostate cancer	4.43e-06	2.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—prostate cancer	4.4e-06	2.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—prostate cancer	4.38e-06	2.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—prostate cancer	4.37e-06	2.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—prostate cancer	4.33e-06	2.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—prostate cancer	4.32e-06	2.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—prostate cancer	4.2e-06	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—prostate cancer	4.2e-06	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JAK2—prostate cancer	4.2e-06	2.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—prostate cancer	4.14e-06	2.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—prostate cancer	4.12e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—prostate cancer	4.1e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—prostate cancer	4.1e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—prostate cancer	4.09e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—prostate cancer	4.09e-06	2.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—prostate cancer	4.08e-06	2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—prostate cancer	4.06e-06	1.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—prostate cancer	4.04e-06	1.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—prostate cancer	4.02e-06	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—prostate cancer	4.01e-06	1.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—prostate cancer	4e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—prostate cancer	3.99e-06	1.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—prostate cancer	3.91e-06	1.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—prostate cancer	3.87e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—prostate cancer	3.83e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—prostate cancer	3.8e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—prostate cancer	3.8e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—prostate cancer	3.78e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—prostate cancer	3.78e-06	1.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—prostate cancer	3.78e-06	1.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—prostate cancer	3.76e-06	1.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—prostate cancer	3.74e-06	1.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—prostate cancer	3.72e-06	1.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—prostate cancer	3.67e-06	1.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—prostate cancer	3.66e-06	1.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—prostate cancer	3.65e-06	1.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—prostate cancer	3.6e-06	1.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—prostate cancer	3.57e-06	1.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—prostate cancer	3.53e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—prostate cancer	3.5e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—prostate cancer	3.47e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—prostate cancer	3.46e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—prostate cancer	3.45e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—prostate cancer	3.44e-06	1.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—prostate cancer	3.43e-06	1.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—prostate cancer	3.41e-06	1.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—prostate cancer	3.38e-06	1.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—prostate cancer	3.37e-06	1.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—prostate cancer	3.37e-06	1.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—prostate cancer	3.33e-06	1.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—prostate cancer	3.28e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—prostate cancer	3.19e-06	1.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—prostate cancer	3.14e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—prostate cancer	3.13e-06	1.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—prostate cancer	3.11e-06	1.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—prostate cancer	3.11e-06	1.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—prostate cancer	3.08e-06	1.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—prostate cancer	3.07e-06	1.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—prostate cancer	3.07e-06	1.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—prostate cancer	3.07e-06	1.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—prostate cancer	2.9e-06	1.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—prostate cancer	2.86e-06	1.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—prostate cancer	2.85e-06	1.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—prostate cancer	2.83e-06	1.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—prostate cancer	2.8e-06	1.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—prostate cancer	2.66e-06	1.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—prostate cancer	2.64e-06	1.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—prostate cancer	2.58e-06	1.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—prostate cancer	2.43e-06	1.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—prostate cancer	2.36e-06	1.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—prostate cancer	2.35e-06	1.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—prostate cancer	2.18e-06	1.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—prostate cancer	2.15e-06	1.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—prostate cancer	1.98e-06	9.74e-06	CbGpPWpGaD
